Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Frontiers in immunology·2026
Same author

Hypericin Suppresses Liver Cancer Through Autophagic Degradation of AKT and Eliciting Antitumor Immune Response.

Cancer science·2026
Same author

Efficacy and Safety of Everolimus in Advanced Unresectable and Progressive Epithelioid Hemangioendothelioma: A Single-Center Case Series.

Drug design, development and therapy·2026
Same author

Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.

Science China. Life sciences·2026
Same author

Molecular characteristics, clonal relatedness and surgical outcomes of pulmonary mixed invasive mucinous and non-mucinous adenocarcinoma: a retrospective cohort study.

Molecular biomedicine·2026
Same author

Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition).

Journal of hematology & oncology·2026

Related Experiment Video

Updated: Jan 14, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

335

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing.

Mengli Wang1, Nan Yao1, Yongming Zhang2

  • 1Department of Pathology, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.

Journal of Visualized Experiments : Jove
|October 27, 2025
PubMed
Summary

Implementing an ISO15189-certified next-generation sequencing (NGS) workflow, featuring automated library preparation and rigorous quality control (QC), enhances accuracy and efficiency for non-small cell lung cancer (NSCLC) precision diagnostics.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.3K

Related Experiment Videos

Last Updated: Jan 14, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

335
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.3K

Area of Science:

  • Molecular diagnostics
  • Genomics
  • Oncology

Background:

  • Targeted therapy for non-small cell lung cancer (NSCLC) requires precise identification of genomic alterations.
  • Next-generation sequencing (NGS) is crucial for detecting these aberrations but faces challenges in complexity and turnaround time.

Purpose of the Study:

  • To introduce an ISO15189-certified NGS workflow for clinical NSCLC molecular diagnostics.
  • To optimize NGS testing for improved accuracy, efficiency, and scalability in precision oncology.

Main Methods:

  • Standardized protocol including tumor cellularity assessment, DNA extraction from FFPE tissues, and bioinformatics analysis.
  • Integration of stringent quality control (QC) at all workflow stages.
  • Automation of NGS library construction (end repair, A-tailing, adapter ligation, hybridization capture, purification).

Main Results:

  • The automated NGS library preparation minimized human error and enhanced reproducibility.
  • Stringent QC measures ensured high data reliability throughout the workflow.
  • The optimized workflow demonstrated improved efficiency and reduced hands-on time.

Conclusions:

  • Rigorous QC and automated library preparation are essential for accurate and scalable clinical NGS testing.
  • This ISO15189-compliant workflow supports precision oncology for NSCLC management.
  • The approach addresses the challenges of complexity and turnaround time in NGS diagnostics.